Loading clinical trials...
Loading clinical trials...
A Prospective, Multicenter Clinical Study of Percutaneous Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events in Patients With Atrial Fibrillation
Conditions
Interventions
Transthoracic Echocardiography
Locations
5
China
Qilu Hospital of Shandong University
Jinan, Shandong, China
Shanghai Songjiang District Central Hospital
Shanghai, Shanghai Municipality, China
Sichuan Mianyang 404 Hospital
Mianyang, Sichuan, China
The first Affiliated Hospital of WMU
Wenzhou, Zhejiang, China
The Second Affiliated Hospital and Yuying Children's Hospital of WMU
Wenzhou, Zhejiang, China
Start Date
November 12, 2020
Primary Completion Date
November 1, 2025
Completion Date
November 1, 2027
Last Updated
December 19, 2022
NCT06585228
NCT05044208
NCT05565599
NCT03609437
NCT05431972
NCT07013396
Lead Sponsor
Lifetech Scientific (Shenzhen) Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions